Related Experiment Video
Updated: May 6, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Pediatric parvovirus B19: spectrum of clinical manifestations
Monica N Valentin1, Philip J Cohen
1Department of Dermatology, New Jersey Medical School, 185 South Orange Ave, Room H-576, Newark, NJ 07103-2714, USA. Philip.Cohen@va.gov.
Insights
Parvovirus B19 infection presents with diverse symptoms, most commonly erythema infectiosum in children. High-risk groups face severe hematologic issues, necessitating clinical diagnosis and symptomatic treatment.
Area of Science:
- Virology and Pediatric Infectious Diseases
Background:
- Parvovirus B19 (PVB19) infection exhibits a wide range of clinical presentations, from asymptomatic cases to severe hematologic complications.
- Erythema infectiosum (EI), or fifth disease, is the most frequent manifestation in children, characterized by a distinctive facial rash.
- While typically self-limiting in healthy children, PVB19 infection poses significant risks to immunocompromised individuals, those with hemolytic anemia, or prenatally exposed infants.
Purpose of the Study:
- To review the clinical spectrum of Parvovirus B19 infection.
- To highlight diagnostic approaches and management strategies for PVB19.
- To discuss the implications of PVB19 in different pediatric populations.
Main Methods:
- Clinical review of Parvovirus B19 infection manifestations.
- Summary of diagnostic criteria, including clinical presentation and serologic testing.
- Overview of current treatment approaches and future vaccine development.
Main Results:
- Parvovirus B19 infection causes varied symptoms, with erythema infectiosum being common in children.
- Diagnosis is primarily clinical, supported by serologic tests.
- High-risk pediatric groups experience more severe, hematologic manifestations.
Conclusions:
- Parvovirus B19 infection requires careful management, especially in vulnerable pediatric populations.
- Symptomatic treatment is the current standard of care.
- Ongoing research aims to develop a vaccine for PVB19.
Abstract:
Parvovirus B19 (PVB19) infection has a varied spectrum of clinical manifestations, ranging from subclinical infection to skin and joint symptoms to hematologic effects with potential fatality. The most common manifestation of PVB19 infection in children is erythema infectiosum (EI). Also known as fifth disease or slapped cheek syndrome, EI presents as an erythematous exanthem limited to the malar eminences that follows a mild prodromal illness. In healthy children, infection is selflimiting and has an excellent prognosis; however, in high-risk pediatric groups (eg, immunocompromised patients, children with hemolytic anemia or prenatal infection), clinical manifestations are hematologic in nature and typically are more severe. Diagnosis often is made clinically. Serologic testing can be confirmatory. Treatment is aimed at symptomatic relief, and a vaccine currently is under investigation.
Related Concept Videos
Viral Meningitis
Cytomegalovirus Disease
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Bacterial Gastroenteritis
Bacterial Meningitis I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations

